Subcutaneous Injection (The Gold Standard) Subcutaneous (Sub-Q) injection involves a small needle delivering the peptide into the fatty layer between the skin and the muscle
Ozempic - Originally developed for diabetes management, this semaglutide-based treatment also provides significant GLP 1 weight loss benefits
It is important to note that there is no established link between GLP-1 receptor agonists and worsening of autoimmune thyroid disease in humans
For example, increasing your daily protein intake to 80120 grams can help preserve muscle mass, while adding more fiber to your diet can address constipation, a common side effect of slowed digestion
It is unknown whether Semaglutide base passes into breast milk, so breastfeeding women should consult a healthcare provider to weigh potential risks and benefits before use
Compounded medications are not FDA-approved, meaning they havent been rigorously tested for safety or efficacy